The escalating cost of developing drugs is due, in part, to time spent assessing compounds that fail further down the drug discovery process. As such, high-content analysis (HCA) is now emerging as ...
CompuCyte Corp. said today that it has completed a restructuring of its operations to focus on its LSC laser scanning cytometers. It plans to release its new LSC instrument in the third quarter. This ...
The high-content cell-imaging market is heating up thanks to two new product releases from Cambridge, Mass.-based CompuCyte. The new iCysâ„¢ Research Imaging Cytometer and iCyteâ„¢ Automated Imaging ...